Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells

American Journal of Hypertension

Volumn 13, Issue 2, 2000, Pages 191-198

  Fukuda, Noboru ^a   Hu, Wen Yang ^a   Kubo, Atsushi ^a   Kishioka, Hirobumi ^a   Satoh, Chikara ^a   Soma, Masayoshi ^a   Izumi, Yoichi ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Receptor; Transforming growth factor ; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; DNA; PHORBOL ESTER DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CULTURE; COMPLEX FORMATION; DNA SYNTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ACTIVIN RECEPTORS, TYPE I; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DNA; DNA PRIMERS; MALE; MUSCLE, SMOOTH, VASCULAR; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED WKY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 0034051005     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00152-1     Document Type: Article

References (43)

1. Moses H.L., Coffey R.J. Jr, Leof E.B., Lyons R.M., Keski-Oja J. Transforming growth factor β regulation of cell proliferation. J Cell Physiol. 5:(suppl):1987;1-7.
2. Majack R.A. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell culture. J Cell Biol. 105:1987;465-471.
3. Goodman L.V., Majack R.A. Vascular smooth muscle cells express distinct transforming growth factor-β receptor phenotypes as a function of cell density in culture. J Biol Chem. 264:1989;5241-5244.
4. Majack R.A., Majesky M.W., Goodman L.V. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β J Cell Biol. 111:1990;239-247.
5. Miyazono K., Hellman U., Wernstedt C., Heldin C.H. Latent high molecular weight complex of transforming growth factor β1 - purification from human platelets and structural characterization. J Biol Chem. 263:1988;6407-6415.
6. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 106:1988;1659-1665.
7. Antonelli-Orlidge A., Saunders K.B., Smith S.R., D'Amore P.A. An activated form of transforming growth factor β is produced by coculture of endothelial cells and pericytes. Proc Natl Acad Sci USA. 866:1989;4544-4548.
8. Laiho M., Keski-Oja J. Growth factors in the regulation of pericellular proteolysis - a review. Cancer Res. 49:1989;2533-2553.
9. Massague J., Like B. Cellular receptors for type β transforming growth factor ligand binding and affinity labeling in human and rodent cell lines . J Biol Chem. 260:1985;2636-2645.
10. Wang X., Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., Weinberg R.A. Expression cloning and characterization of the TGF-β type III receptor. Cell. 67:1991;797-805.
11. Attisano L., Carcamo J., Ventura F., Weis F.M.B., Massague J., Wrana J.L. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:1993;671-680.
12. Franzen P., Dijeke P., Ichijo H., Yamashita H., Schultz P., Helden C., Miyazono K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell. 75:1993;681-692.
13. Takeuchi K., Nakamura N., Cook N.S., Pratt R.E., Dzau V.J. Angiotensin II can regulate gene expression by the AP-1 binding sequence via protein kinase C dependent pathway. Biochem Biophys Res Commun. 172:1990;1189-1194.
14. Stouffer G.A., Owens G.K. Angiotensin II induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β Circ Res. 70:1992;820-828.
15. Gibbons G.H., Pratt R.E., Dzau V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia autocrine transforming growth factor β1 expression determines growth response to angiotensin II . J Clin Invest. 90:1992;456-461.
16. Geisterfer A.A.T., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 62:1988;749-756.
17. Bunkenburge B., Amelsvoort T., Rogg H., Wood J.M. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 20:1992;746-754.
18. Koibuchi Y., Lee W.S., Gibbons G.H., Pratt R.E. Role of transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension. 21:1993;1046-1050.
19. Itoh H., Mukoyama M., Pratt R.E., Gibbons G.H., Dzau V.J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 91:1993;2268-2274.
20. Ross R. The smooth muscle cell - II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 50:1971;172-186.
21. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 51:1949;660-672.
22. Massague J. Subunit structure of a high-affinity receptor for type β-transforming growth factor evidence for a disulfide-linked glycosylated receptor complex . J Biol Chem. 260:1985;7059-7066.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
24. Mocharla H., Mocharla R., Hocks M.E. Coupled reverse transcription-polymerase chain reaction (RT-PCR) as a sensitive and rapid method for isozyme genotyping. Gene. 93:1990;271-275.
25. Chan Y.L., Lin A., McNally J., Pelleg D., Meyuhas O., Wool I. The primary structure of rat ribosomal protein L19. J Biol Chem. 262:1987;1111-1115.
26. Nabel E.G., Shum G.L., Pompili V.J., Yang Z.-Y., San H., Shu H.B., Liptay S., Gold L., Gordon D., Derynck R., Nabel G.L. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
27. Hamet P., Hadrava V., Kruppa U., Tremblay J. Transforming growth factor β1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension. 17:1991;896-901.
28. Nikol S., Inser J.M., Pickering J.G., Kearney M., Leclerc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
29. Majesky M.W., Linder V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
30. Ross R., Masuda J., Raines E.W., Gown A.M., Katsuda S., Sasahara M., Malden L.T., Masuko H., Sato H. Localization of PDGF-B protein in macrophages in all stages of atherogenesis. Science. 248:1990;1009-1012.
31. Fukuda N., Tremblay J., Hamet P. Participation of proteolysis and transforming growth factor β1 activation in growth of cultured smooth muscle cells from spontaneously hypertensive rats. Genet Hypertens. 218:1992;227-229.
32. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 93:1994;1172-1178.
33. Chen R., Ebner R., Derrynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science. 260:1993;1335-1338.
34. Massague J. TGFβ signaling receptors, transducers, and Mad proteins . Cell. 85:1996;947-950.
35. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
36. Boyd F.T., Massague J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem. 264:1989;2272-2278.
37. Fukuda N., Kubo A., Izumi Y., Soma M., Kanmatsuse K. Characteristics and expression of transforming growth factor-β receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 13:1995;831-837.
38. McCaffrey T.A., Consigili S., Du B., Falcone D.J., Sanborn T.A., Spokojny A.M., Bush H.L. Jr. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. J Clin Invest. 96:1995;2667-2675.
39. McCaffrey T.A., Du B., Consigli S., Szabo P., Bray P.J., Hartner L., Weksler B.B., Sanborn T.A., Bergman G., Bush H.L. Jr. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest. 100:1997;2182-2188.
40. Wakefield L.M., Smith D.M., Masui T., Harris C.C., Sporn M.B. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol. 105:1987;965-975.
41. Molloy C.J., Taylor D.S., Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 268:1993;7338-7345.
42. Schorb W., Peeler T.C., Madigan N.N., Conrad K.M., Baker K.M. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem. 269:1994;19626-19632.
43. 1A cells cross-talk between angiotensin II and interleukin-6 nuclear signaling . J Biol Chem. 270:1995;19059-19065.